the Effect of Pregabalin on Postoperative Pain and Opioid Consumption in Spine Surgery

Sponsor
Assiut University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05083793
Collaborator
(none)
90
1
2
21
4.3

Study Details

Study Description

Brief Summary

The effect of pregabalin on post-operative pain and opioid consumption in spine surgery, a prospective, randomized, controlled study

Condition or Disease Intervention/Treatment Phase
  • Drug: Pregabalin 150mg
  • Other: Placebo
Phase 2

Detailed Description

Aim of the work:

The aim of our study is to compare the analgesic effect of pre-emptive oral pregabalin 150mg on acute postoperative pain and opioid consumption in spine surgery. Evaluated by visual analog scale (VAS)

primary outcome measure is the total amount of rescue morphine received by patients for 24h postoperatively.

secondary outcome measures include level of acute postoperative pain by VAS, and duration of hospital stay

Patients and methods :

This study will be carried out after being approved from the Medical Research Ethical Committee, Faculty of Medicine, Assiut University, Assiut, Egypt, and after obtaining a written informed consents from all participating patients.

inclusion criteria: This prospective randomized clinical study will include eighty patients with ASA I-II, aged 18-60 years scheduled for spine surgery

Exclusion criteria : Excluded from the study are patients with known allergy to the study drugs, significant cardiac, respiratory, renal, CNS or hepatic disease, drug or alcohol abuse, pregnant women, patients refusing participation and psychiatric or mental illness that would interfere with perception and assessment of pain.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Care Provider)
Masking Description:
care provider
Primary Purpose:
Supportive Care
Official Title:
The Effect of Pregabalin on Post-operative Pain and Opioid Consumption in Spine Surgery, a Prospective, Randomized, Controlled Study
Actual Study Start Date :
Apr 1, 2020
Anticipated Primary Completion Date :
Jan 1, 2022
Anticipated Study Completion Date :
Jan 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Study group

patients have spine surgery receive oral pregabalin 150 mg 1 hour before surgery

Drug: Pregabalin 150mg
The effect of pregabalin on post-operative pain
Other Names:
  • Pregabalin
  • Placebo Comparator: Placebo group

    patients will receive placebo 1 hour before surgery with a sip of water.

    Other: Placebo
    patients will receive placebo one hour before operation

    Outcome Measures

    Primary Outcome Measures

    1. Morphia dose [24 hour postoperative]

      the total amount of rescue morphine received by patients for 24h postoperatively.

    Secondary Outcome Measures

    1. Postoperative pain [24 hour postoperative]

      post operative VAS score

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • : This prospective randomized clinical study will include eighty patients with ASA I-II, aged 18-60 years scheduled for spine surgery
    Exclusion Criteria:
    • : Excluded from the study are patients with known allergy to the study drugs, significant cardiac, respiratory, renal, CNS or hepatic disease, drug or alcohol abuse, pregnant women, patients refusing participation and psychiatric or mental illness that would interfere with perception and assessment of pain.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mahmoud Maher Assiut Egypt 11174

    Sponsors and Collaborators

    • Assiut University

    Investigators

    • Study Chair: Mahmoud Maher, MD, Assiut University Hospitals

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Mohamed galal aly, Professor of anesthesia and intensive care, Assiut University
    ClinicalTrials.gov Identifier:
    NCT05083793
    Other Study ID Numbers:
    • 17101526
    First Posted:
    Oct 19, 2021
    Last Update Posted:
    Oct 19, 2021
    Last Verified:
    Oct 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Mohamed galal aly, Professor of anesthesia and intensive care, Assiut University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 19, 2021